Derek Chalmers
2017
In 2017, Derek Chalmers earned a total compensation of $3.5M as President and Chief Executive Officer at Cara Therapeutics, a 141% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $233,400 |
|---|---|
| Option Awards | $2,753,848 |
| Salary | $526,300 |
| Other | $8,100 |
| Total | $3,521,648 |
Chalmers received $2.8M in option awards, accounting for 78% of the total pay in 2017.
Chalmers also received $233.4K in non-equity incentive plan, $526.3K in salary and $8.1K in other compensation.
Rankings
In 2017, Derek Chalmers' compensation ranked 2,997th out of 14,666 executives tracked by ExecPay. In other words, Chalmers earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,997 out of 14,666 | 80th |
Division Manufacturing | 1,034 out of 5,772 | 82nd |
Major group Chemicals And Allied Products | 279 out of 2,075 | 87th |
Industry group Drugs | 212 out of 1,731 | 88th |
Industry Pharmaceutical Preparations | 168 out of 1,333 | 87th |
Source: SEC filing on April 24, 2019.
Chalmers' colleagues
We found two more compensation records of executives who worked with Derek Chalmers at Cara Therapeutics in 2017.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019